Corbus Pharmaceuticals Reports 2015 Financial Results and Provides 2016 Business Update
NORWOOD, MA--(Marketwired - March 29, 2016) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic …